• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Could Faecalibacterium prausnitzii Amount in the Gut Microbiota Be Used to Monitor the COVID-19 Severity?

作者信息

Demirci Mehmet

机构信息

Department of Medical Microbiology, Kırklareli University Faculty of Medicine, Kırklareli, Turkey.

出版信息

Turk J Gastroenterol. 2022 Oct;33(10):899-900. doi: 10.5152/tjg.2022.22100.

DOI:10.5152/tjg.2022.22100
PMID:36098357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9623143/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abeb/9623143/c6ce878aefde/tjg-33-10-899_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abeb/9623143/c6ce878aefde/tjg-33-10-899_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abeb/9623143/c6ce878aefde/tjg-33-10-899_f001.jpg

相似文献

1
Could Faecalibacterium prausnitzii Amount in the Gut Microbiota Be Used to Monitor the COVID-19 Severity?肠道微生物群中普拉梭菌的数量能否用于监测新冠病毒疾病的严重程度？
Turk J Gastroenterol. 2022 Oct;33(10):899-900. doi: 10.5152/tjg.2022.22100.
2
in Differentiated Thyroid Cancer Patients Treated with Radioiodine.在接受放射性碘治疗的分化型甲状腺癌患者中。
Nutrients. 2023 Jun 8;15(12):2680. doi: 10.3390/nu15122680.
3
Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma.过敏性哮喘儿童肠道微生物群中嗜黏蛋白阿克曼氏菌和普拉梭菌水平降低。
Allergol Immunopathol (Madr). 2019 Jul-Aug;47(4):365-371. doi: 10.1016/j.aller.2018.12.009. Epub 2019 Feb 11.
4
Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.饮食诱导的肠道微生物变化与糖尿病之间的因果关系：将普拉梭菌粪菌移植用于预防糖尿病的新策略。
Int J Mol Sci. 2018 Nov 22;19(12):3720. doi: 10.3390/ijms19123720.
5
Action and function of Faecalibacterium prausnitzii in health and disease.普拉梭菌在健康与疾病中的作用和功能。
Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):643-648. doi: 10.1016/j.bpg.2017.09.011. Epub 2017 Sep 18.
6
Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.银屑病和炎症性肠病中保护性普拉梭菌的类似耗竭，但化脓性汗腺炎中不存在。
J Crohns Colitis. 2016 Sep;10(9):1067-75. doi: 10.1093/ecco-jcc/jjw070. Epub 2016 Mar 12.
7
Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps.肠道微生物组与肠腺瘤性息肉患者 APC 基因突变相关。
Int J Biol Sci. 2020 Jan 1;16(1):135-146. doi: 10.7150/ijbs.37399. eCollection 2020.
8
Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.在复发性艰难梭菌感染患者中，粪便微生物群移植后普拉梭菌丰度增加。
PLoS One. 2021 Apr 9;16(4):e0249861. doi: 10.1371/journal.pone.0249861. eCollection 2021.
9
The association of type II diabetes with gut microbiota composition.2型糖尿病与肠道微生物群组成的关联。
Microb Pathog. 2017 Sep;110:630-636. doi: 10.1016/j.micpath.2017.07.034. Epub 2017 Jul 21.
10
Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa.比较分析普拉梭菌（Faecalibacterium prausnitzii）基因组表明其具有高水平的基因组可塑性，并证明其需要划分为新的种级分类单元。
BMC Genomics. 2018 Dec 14;19(1):931. doi: 10.1186/s12864-018-5313-6.

引用本文的文献

1
The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity.短链脂肪酸在慢性低度炎症和肥胖中的表观遗传调控作用。
Front Immunol. 2024 Mar 27;15:1380476. doi: 10.3389/fimmu.2024.1380476. eCollection 2024.
2
as a novel next generation probiotic against influenza.作为一种新型的抗流感下一代益生菌。
Front Immunol. 2024 Mar 12;15:1347676. doi: 10.3389/fimmu.2024.1347676. eCollection 2024.

本文引用的文献

1
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.促炎肠道微生物组特征 SARS-CoV-2 感染患者，抗炎细菌网络连通性降低与严重 COVID-19 相关。
Front Cell Infect Microbiol. 2021 Nov 17;11:747816. doi: 10.3389/fcimb.2021.747816. eCollection 2021.
2
Beware of pharyngeal Fusobacterium nucleatum in COVID-19.警惕 COVID-19 中的咽峡部核梭杆菌。
BMC Microbiol. 2021 Oct 11;21(1):277. doi: 10.1186/s12866-021-02336-6.
3
Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity.
主要肠道细菌种类变化与新型冠状病毒肺炎严重程度之间相关性的临床意义
Engineering (Beijing). 2020 Oct;6(10):1178-1184. doi: 10.1016/j.eng.2020.05.013. Epub 2020 Jun 8.
4
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.
5
Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma.过敏性哮喘儿童肠道微生物群中嗜黏蛋白阿克曼氏菌和普拉梭菌水平降低。
Allergol Immunopathol (Madr). 2019 Jul-Aug;47(4):365-371. doi: 10.1016/j.aller.2018.12.009. Epub 2019 Feb 11.